Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Avelin F. Aghokeng"'
Autor:
Danielle S. Koumba Mavoungou, Linda Bohou Kombila, Neil M. Longo Pendy, Schedy E. Koumba Moukouama, Sonia Etenna Lekana-Douki, Gaël D. Maganga, Eric M. Leroy, Avelin F. Aghokeng, Nadine N’dilimabaka
Publikováno v:
Viruses, Vol 16, Iss 7, p 1015 (2024)
Hepatitis B virus (HBV) infection leads to around 800,000 deaths yearly and is considered to be a major public health problem worldwide. However, HBV origins remain poorly understood. Here, we looked for bat HBV (BtHBV) in different bat species in Ga
Externí odkaz:
https://doaj.org/article/1bf64e462829483585a18c298250c682
Autor:
Armando B. D. Djiyou, Calixte Ida Penda, Yoann Madec, Grace Dalle Ngondi, Astrid Moukoko, Marie Varloteaux, Laure-Amélie de Monteynard, Cecile Moins, Carole Else Eboumbou Moukoko, Avelin F. Aghokeng
Publikováno v:
BMC Pediatrics, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Achieving the UNAIDS 95% sustained viral suppression (VS) rate requires considerable global efforts, particularly among adolescents living with HIV (ALHIV) who are often associated with high rates of virological failure (VF). In t
Externí odkaz:
https://doaj.org/article/841e15c5301a4c73a6df43275d93eccf
Autor:
Gaëlle F. Tchouwa, Sabrina Eymard-Duvernay, Amandine Cournil, Nadine Lamare, Laetitia Serrano, Christelle Butel, Silvia Bertagnolio, Eitel Mpoudi-Ngole, Elliot Raizes, Avelin F. Aghokeng
Publikováno v:
EClinicalMedicine, Vol 1, Iss , Pp 21-27 (2018)
Background: Population-based studies to estimate viral load (VL) suppression and rate of acquired HIV drug resistance (ADR) are essential in sub-Saharan Africa. We conducted the first nationally representative study estimating VL suppression and ADR
Externí odkaz:
https://doaj.org/article/edc81672ac284b6988b21997b56fa49d
Autor:
Berthe A. Iroungou, Pamela Boundzanga Moussavou, Eric Elguero, Jamal Makran, Berthold Bivigou-Mboumba, Elise Wora, Jean R. Nzenze, Fabien Roche Niama, Avelin F. Aghokeng
Publikováno v:
IJID Regions. 5:13-17
To estimate the seroprevalence of anti-SARS-CoV-2 antibodies in the general population in Gabon, Central Africa.From May to July 2021, a cross-sectional study involving participants recruited in the general population in three districts in Gabon was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d59665d05745892135a8b95dc67d8b4
https://doi.org/10.1016/j.ijregi.2022.08.006
https://doi.org/10.1016/j.ijregi.2022.08.006
Autor:
Fabien R, Niama, Félix, Koukouikila-Koussounda, Pembé Issamou, Mayengue, Eric, Elguero, Tarcisse Baloki, Ngoulou, Victor, Levier, Jamal, Makran, Berthe A, Iroungou, Avelin F, Aghokeng
Publikováno v:
IJID Regions (Online). 5
To estimate the seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies in the general population in the Republic of Congo.In this cross-sectional study, conducted from June to July 2021, participants were recruited
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c2b9d86d0f55a23d15e703d236360782
https://pubmed.ncbi.nlm.nih.gov/36217501
https://pubmed.ncbi.nlm.nih.gov/36217501
Autor:
Jéordy D, Engone-Ondo, Michelle, Bignoumba, Pamela, Boundzanga Moussavou, Amahani, Gafou, Abdoulaye, Diane, Leslie Monica, Yangawagou, Roland Fabrice, Kassa Kassa, Richard, Onanga, Augustin, Mouinga-Ondémé, Avelin F, Aghokeng
Publikováno v:
The Journal of antimicrobial chemotherapy. 77(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e8e53e5898dc274d6a1d41516a97d0e4
https://pubmed.ncbi.nlm.nih.gov/35474382
https://pubmed.ncbi.nlm.nih.gov/35474382
Autor:
Serge Clotaire Billong, Amandine Cournil, Fatim Cham, Lloyd Mulenga, Juliet Asio, Halimatou Diop-Ndiaye, Seth C Inzaule, Meg Doherty, Avelin F. Aghokeng, Do T Nhan, Amalia Girón-Callejas, Michael R. Jordan, Silvia Bertagnolio, Fatou Niasse-Traore, Deogratius Ssemwanga, Santiango Avila-Rios, Vu Quoc Dat
Publikováno v:
AIDS (London, England). 34(13)
OBJECTIVE We aimed to assess the frequency of tenofovir (TDF) resistance in people failing tenofovir/lamivudine or emtricitabine (XTC)/nonnucleotide reverse-transcriptase inhibitor-based first-line antiretroviral treatment (ART) using data from 15 na
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7226f3cf1774ba103bdf4426029e6cbb
https://pubmed.ncbi.nlm.nih.gov/32694410
https://pubmed.ncbi.nlm.nih.gov/32694410
Autor:
Serge C Billong, Joseph Fokam, Armand S Nkwescheu, Etienne Kembou, Pascal Milenge, Zephirin Tsomo, Grace Ngute Dion, Avelin F Aghokeng, Eitel N Mpoudi, Peter M Ndumbe, Vittorio Colizzi, Jean B Elat Nfetam
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e36777 (2012)
BACKGROUND: Rapid scale-up of antiretroviral therapy (ART) in resource-limited settings is accompanied with an increasing risk of HIV drug resistance (HIVDR), which in turn could compromise the performance of national ART rollout programme. In order
Externí odkaz:
https://doaj.org/article/450ebc8985364e239928d4a02f1f36b6
Autor:
Elliot Raizes, Amandine Cournil, Gaëlle F. Tchouwa, Christelle Butel, Laetitia Serrano, Avelin F. Aghokeng, Nadine Lamare, Sabrina Eymard-Duvernay, Silvia Bertagnolio, Eitel Mpoudi-Ngole
Publikováno v:
EClinicalMedicine
Background Population-based studies to estimate viral load (VL) suppression and rate of acquired HIV drug resistance (ADR) are essential in sub-Saharan Africa. We conducted the first nationally representative study estimating VL suppression and ADR i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7ec4863b8833d7ca3f656ce2c17ecc0
http://europepmc.org/articles/PMC6537545
http://europepmc.org/articles/PMC6537545
Autor:
Gaëlle F, Tchouwa, Sabrina, Eymard-Duvernay, Amandine, Cournil, Nadine, Lamare, Laetitia, Serrano, Christelle, Butel, Silvia, Bertagnolio, Eitel, Mpoudi-Ngole, Elliot, Raizes, Avelin F, Aghokeng, Gaëlle Francine, Tchouwa
Publikováno v:
Journal of Antimicrobial Chemotherapy. 73:2468-2474
Background Pretreatment HIV drug resistance (PDR) has the potential to affect treatment outcome and mortality. We present here the first nationally representative PDR study conducted in Cameroon. Methods From February to July 2015, HIV-infected ART i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fefb47a633b1ed4e6e99e97cc10f5dff
https://doi.org/10.1093/jac/dky221
https://doi.org/10.1093/jac/dky221